HKSE:08189 (China)
Â
Class H
HK$
0.26
-0.0050 (-1.92%)
Aug 28
Business Description
Tianjin TEDA Biomedical Engineering Co Ltd
ISIN : CNE1000004H7
Share Class Description:
HKSE:08189: Class HTotal Employee Number:
273Compare
Compare
Traded in other countries / regions
08189.Hong KongTJJ.Germany IPO Date
2002-06-18Description
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.05 | |||||
Debt-to-Equity | 8.98 | |||||
Debt-to-EBITDA | -1.01 | |||||
Interest Coverage | 1.69 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.22 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.3 | |||||
3-Year EBITDA Growth Rate | -275.6 | |||||
3-Year EPS without NRI Growth Rate | 48.9 | |||||
3-Year FCF Growth Rate | -36.4 | |||||
3-Year Book Growth Rate | -47.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.14 | |||||
9-Day RSI | 73.22 | |||||
14-Day RSI | 74.47 | |||||
3-1 Month Momentum % | -29.65 | |||||
6-1 Month Momentum % | -54.84 | |||||
12-1 Month Momentum % | -69.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.75 | |||||
Quick Ratio | 0.5 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 54.85 | |||||
Days Sales Outstanding | 13.77 | |||||
Days Payable | 15.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4 | |||||
Shareholder Yield % | -11.57 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 6.83 | |||||
Operating Margin % | 1.23 | |||||
Net Margin % | -17.43 | |||||
EBITDA Margin % | -20.95 | |||||
FCF Margin % | -11.87 | |||||
OCF Margin % | -10.29 | |||||
ROE % | -210.68 | |||||
ROA % | -27.31 | |||||
ROIC % | 2.2 | |||||
3-Year ROIIC % | -70.49 | |||||
ROC (Joel Greenblatt) % | -91.11 | |||||
ROCE % | -171.22 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.93 | |||||
PB Ratio | 25.5 | |||||
EV-to-EBIT | -5.3 | |||||
EV-to-EBITDA | -5.3 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | -9.35 | |||||
Price-to-GF-Value | 1.34 | |||||
Price-to-Median-PS-Value | 0.91 | |||||
Earnings Yield (Greenblatt) % | -18.87 | |||||
FCF Yield % | -12.55 | |||||
Forward Rate of Return (Yacktman) % | -40.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tianjin TEDA Biomedical Engineering Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 575.093 | ||
| EPS (TTM) (HK$) | -0.048 | ||
| Beta | 0.1483 | ||
| 3-Year Sharpe Ratio | 0.56 | ||
| 3-Year Sortino Ratio | 1.51 | ||
| Volatility % | 60.68 | ||
| 14-Day RSI | 74.47 | ||
| 14-Day ATR (HK$) | 0.018856 | ||
| 20-Day SMA (HK$) | 0.20825 | ||
| 12-1 Month Momentum % | -69.57 | ||
| 52-Week Range (HK$) | 0.114 - 0.485 | ||
| Shares Outstanding (Mil) | 2,133.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tianjin TEDA Biomedical Engineering Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tianjin TEDA Biomedical Engineering Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tianjin TEDA Biomedical Engineering Co Ltd Frequently Asked Questions
What is Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189)'s stock price today?
The current price of HKSE:08189 is HK$0.26. The 52 week high of HKSE:08189 is HK$0.49 and 52 week low is HK$0.11.
When is next earnings date of Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189)?
The next earnings date of Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189) is .
Does Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189) pay dividends? If so, how much?
Tianjin TEDA Biomedical Engineering Co Ltd(HKSE:08189) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Tianjin TEDA Biomedical Engineering Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers